After treatment, primary outcomes such as 28-day mortality from all causes and in-hospital mortality (Table 2) were significantly lower in the study group than in the control group ( and ), and the 28-day Kaplan-Meier survival curve was higher in the study group than in the control group (Figures 3 and 4).